Projecten per jaar
Persoonlijk profiel
Expertise
Thomas Ertveldt is a junior postdoc at the VUB’s Molecular Imaging and Therapy (MITH) research group. He recently concluded his doctoral studies revolving the immunogenic properties of targeted radionuclide therapy (TRT) mediated by single domain antibodies (sdAb’s) and immune imaging upon immune intervention. With his research, he aspires to improve knowledge and tools to increase patients response as well as reduce adverse effects to novel therapies such as TRT and immunotherapy.
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Thomas Ertveldt actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Projecten
- 1 Afgelopen
Onderzoeksoutput
-
Efficient α and β- radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model
Ceuppens, H., Pombo Antunes, A. R., Navarro, L., Ertveldt, T., Berdal, M., Nagachinta, S., De Ridder, K., Lahoutte, T., Keyaerts, M., Devoogdt, N., Goyvaerts, C., D'Huyvetter, M. & Breckpot, K., jan 2025, In: European Journal of Nuclear Medicine and Molecular Imaging. 52, 2, blz. 444-457 14 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand3 Citaten (Scopus)5 Downloads (Pure) -
Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer
Dierick, H., Navarro, L., Ceuppens, H., Ertveldt, T., Pombo Antunes, A. R., Keyaerts, M., Devoogdt, N., Breckpot, K., D'Huyvetter, M., Lahoutte, T., Caveliers, V. & Bridoux, J., dec 2024, In: EJNMMI Radiopharmacy and Chemistry. 9, 1, 14 blz., 54.Onderzoeksoutput: Article › peer review
Open AccessBestand3 Citaten (Scopus)18 Downloads (Pure) -
Sustained release of a human pd-l1 single-domain antibody using peptide-based hydrogels
Heremans, J., Maximilian Awad, R., Bridoux, J., Ertveldt, T., Caveliers, V., Madder, A., Hoogenboom, R., Devoogdt, N., Ballet, S., Hernot, S., Breckpot, K. & Martin, C., mrt 2024, In: European Journal of Pharmaceutics and Biopharmaceutics. 196, 196, 21 blz., 114183.Onderzoeksoutput: Article › peer review
Open AccessBestand5 Citaten (Scopus)153 Downloads (Pure) -
Accepted poster session at ImmunoRad 2023: Targeted alpha therapy using Actinium-225 radiolabeled single domain antibodies induces antigen-specific immune responses and instills immunomodulation both systemically and at the tumor microenvironment
Ertveldt, T., Krasniqi, A., Ceuppens, H., Puttemans, J., Dekempeneer, Y., De Jonghe, K., de Mey, W., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., Goyvaerts, C., De Veirman, K., Morgenstern, A., Bruchertseifer, F., Keyaerts, M., Devoogdt, N., D'Huyvetter, M. & Breckpot, K., 27 sep 2023.Onderzoeksoutput: Poster
-
Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT
Zeven, K., De Groof, T. W. M., Ceuppens, H., Awad, R. M., Ertveldt, T., de Mey, W., Meeus, F., Raes, G., Breckpot, K. & Devoogdt, N., 20 sep 2023, In: Frontiers in Immunology. 14, 1, 16 blz., 1268900.Onderzoeksoutput: Article › peer review
Open AccessBestand9 Citaten (Scopus)45 Downloads (Pure)
Datasets
-
Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model
Breckpot, K. (Creator) & Ertveldt, T. (Creator), Molecular Cancer Therapy, 16 dec 2024
DOI: https://doi.org/10.1158/1535-7163.c.6543403.v1
Dataset
-
Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8+ T cell and iNKT cell activating mRNA vaccine
Breckpot, K. (Creator) & Ertveldt, T. (Creator), Theranostics, 16 dec 2024
Dataset
-
Dataset of Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT
De Groof, T. (Creator), Zeven, K. (Creator), Ceuppens, H. (Creator), Awad, R. M. (Creator), Ertveldt, T. (Creator), de Mey, W. (Creator), Meeus, F. (Creator), Raes, G. (Creator), Breckpot, K. (Creator) & Devoogdt, N. (Creator), Zenodo, 24 mrt 2025
Dataset
Prijzen
-
Alavi-Mandell Award
Ertveldt, Thomas (Recipient), 4 apr 2024
Prijs: Prize (including medals and awards)
Bestand -
Marie-Louise Lottin Award
Ertveldt, Thomas (Recipient), nov 2024
Prijs: Prize (including medals and awards)
Bestand
Activiteiten
-
Efficient α and β- radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model.
Hannelore Ceuppens (Speaker), Ana Rita Pombo Antunes (Contributor), Laurent Navarro (Contributor), Thomas Ertveldt (Contributor), Marion Berdal (Contributor), Surasa Nagachinta (Contributor), Kirsten De Ridder (Contributor), Marleen Keyaerts (Contributor), Nick Devoogdt (Contributor), Cleo Goyvaerts (Contributor), Matthias D'Huyvetter (Contributor) & Karine Breckpot (Contributor)
23 okt 2024Activiteit: Talk or presentation at a conference
-
The development of radiolabeled nanobodies against the next-generation immune checkpoint TIGIT for non-invasive immune phenotyping of tumors
Katty Zeven (Speaker), Timo De Groof (Contributor), Robin Maximilian Awad (Contributor), Wout De Mey (Contributor), Thomas Ertveldt (Contributor), Hannelore Ceuppens (Contributor), Kevin De Jonghe (Contributor), Geert Raes (Contributor), Marleen Keyaerts (Contributor), Karine Breckpot (Contributor) & Nick Devoogdt (Contributor)
16 mrt 2023Activiteit: Talk or presentation at a conference
-
Cancer Biotherapy and Radiopharmaceuticals (Tijdschrift)
Thomas Ertveldt (Peer reviewer)
1 okt 2023 → 31 okt 2023Activiteit: Publication peer-review
-
Development and evaluation of Nanobody tracers for non-invasive nuclear imaging of the next generation immune checkpoint TIGIT
Katty Zeven (Speaker), Timo De Groof (Contributor), Hannelore Ceuppens (Contributor), Robin Maximilian Awad (Contributor), Thomas Ertveldt (Contributor), Geert Raes (Contributor), Karine Breckpot (Contributor) & Nick Devoogdt (Contributor)
18 sep 2023 → 20 sep 2023Activiteit: Talk or presentation at a conference
-
SCK NMA-talk
Thomas Ertveldt (Presenter), Nick Devoogdt (Invited speaker) & Matthias D'Huyvetter (Contributor)
14 nov 2023Activiteit: Talk or presentation at a workshop/seminar
Scriptie
-
Immunogenic effect of targeted radionuclide therapy-induced tumor cell death
Auteur: Ertveldt, T., Breckpot, K., Keyaerts, M., D'Huyvetter, M. & Krasniqi, A., 15 jun 2019Begeleider: Krasniqi, A. (Promotor)
Scriptie/Masterproef: Master's Thesis